COVID-19 vaccine in India: While the government of India is talking about the preparedness of COVID-19 vaccination, Dr Randeep Guleria, Director, AIIMS Delhi, said that the coronavirus vaccine in India won’t be available in sufficient doses to give to everyone.
In India, we now have vaccines which are in their final trial stage, Randeep Guleria said on coronavirus vaccine. He was hopeful that by the end of this month or early next month we should get emergency use authorisation from Indian regulatory authorities to start giving the coronavirus vaccine to the public.
“In the beginning, the COVID-19 vaccine in India won’t be available in sufficient doses to give to everyone. We need a priority list to see that we vaccinate those who’ve high chances of dying due to Covid. Elderly, people with comorbidities and front line workers should be vaccinated first,” he added.
He further said that the work was going on at war-footing both at the centre and state level for vaccine distribution plan in terms of maintaining the cold chain, having appropriate storehouses available, developing strategy, training vaccinators and availability of syringes.
“Now, we’ve seen a decline in current wave and I hope this will continue if we are able to have a good COVID-19 appropriate behaviour,” he said, adding that “We’re close to having a big change related to a pandemic if we manage this behaviour for next 3 months.”
“Chennai trial case is an incidental finding rather than related to the vaccine. When we vaccinate a large number of people, some of them may have some other disease, which may not be related to the vaccine, he said on vaccine impact during Chennai trial.
There was good data available that the vaccines are very safe, Guleria said. Also, he said that the safety and efficacy of the vaccine would not be compromised at all.
“70,000-80,000 volunteers have been given the vaccine and no significant serious adverse effects were seen,” he said, adding that the data shows that in the short term vaccine is safe.